Article
President Trump Announces And Then Pauses 100 Percent Tariff On Branded Pharmaceuticals From Companies Without U.S. Factories Under Construction
On Tuesday, September 30, as part of the administration's announcement of a Most Favored Nation (MFN) pricing agreement with Pfizer, the White House stated that tariffs on other branded drug manufacturers would be paused while MFN negotiations with such manufacturers continue, in addition to announcing a specific three-year grace period for tariffs on Pfizer's products

Manatt, Phelps & Phillips, LLP
